Heligenics AND The Jackson Laboratory announce new collaboration on ERBB2 breast cancer gene

(Jackson Laboratory) Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory. This joint project will make available the functional output of Variants of Unknown Significance throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase, a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news